Search Results 7541-7550 of 34176 for oral
The eligible HNSCC primary tumor locations are oropharynx, oral cavity, hypopharynx, and larynx. Documentation of p16 status (positive or negative) by local ...
Receipt of oral anti-rejection or immunomodulatory drugs (including TCZ) within the past 3 months;; Participation in other drug clinical trials ...
If subject is currently receiving oral aminosalicylate (e.g., mesalamine products, balsalazide, or sulfasalazine):; Subject is eligible provided the subject ...
recombinant human growth hormone [rhGH] insulin, oral beta adrenergic agonists, megestrol acetate, dronabinol, metformin or other drugs) which might ...
... oral medications. Any severe and/or uncontrolled medical conditions or other conditions that, in the treating physician's opinion, could adversely impact ...
Oral contraceptive (combined or progesterone only) in females when combined with a chemical or physical barrier method;; Double-barrier method (any ...
Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating the ...
ringworm of the trunk (tinea [pityriasis] versicolor). Oxiconazole is available only with your doctor's prescription. This product is available in the following ...
Received iodinated intravenous contrast within 3 months of registration; avoidance of iodinated oral contrast is also preferred but not strictly required ...
... Oral and throat cancer, Laryngeal cancer, Skin tumor · Jamie J. Van Gompel, M.D.. Rochester, MN. Area of Focus: Epilepsy surgery ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.